Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.05.2011 | Case report

Azathioprine

Pancytopenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Wee JS, Marinaki A, Smith CH.Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity. BMJ 342: 762-764, No. 7800, 2 Apr 2011. Available from: URL: http://dx.doi.org/10.1136/bmj.d1417 - United Kingdom Wee JS, Marinaki A, Smith CH.Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity. BMJ 342: 762-764, No. 7800, 2 Apr 2011. Available from: URL: http://​dx.​doi.​org/​10.​1136/​bmj.​d1417 - United Kingdom
Metadaten
Titel
Azathioprine
Pancytopenia: case report
Publikationsdatum
01.05.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113510-00036

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Dronedarone

Case report

Carbimazole

Case report

Diclofenac

Case report

Tetanus vaccine